FILTER

FILTERED INTERVIEW RESULTS

Michael Quirmbach

CEO & PRESIDENT, CORDENPHARMA
CordenPharma is enjoying great demand for its increasing array of services.

Alan Petro

CEO, NEW VISION PHARMACEUTICALS
New Vision Pharmaceuticals explains how it is developing Blow-Fill-Seal technology and other services.

Luca Candioli

OWNER & GENERAL MANAGER, CANDIOLI PHARMA
Italian animal health company Candioli explains how it intends to double in size during the next five years.

Paolo Tubertini

CEO, OLON
Olon has expanded from production of APIs and intermediates to include CDMO and Biotech operations in Italy and beyond.

Manni Kantipudi & Ramesh Subramanian

CEO & CCO, ARAGEN LIFE SCIENCES
Aragen Life Sciences continues its rapid expansion and celebrates its best year ever.

Salvatore Butti

PRESIDENT, ASSOSALUTE - FEDERCHIMICA
Assosalute represents non-prescription medical products in Italy and explains how easing regulations could be of huge benefit to Italians and the healthcare system.

Dr. Siva Samy

CEO & CHIEF PRODUCT STRATEGIST, VALGENESIS
ValGenesis explains how it streamlines the validation process to allow real-time access to validation documents and data enabling various stakeholders to achieve compliance efficiently.

Michael Kauffman

CEO, KARYOPHARM THERAPEUTICS
GBR speaks to Karyopharm Therapeutics about the commercialization of XPOVIO.

Paolo Russolo

PRESIDENT, ASCHIMFARMA – FEDERCHIMICA
Aschimfarma explains to GBR how Italian producers of APIs are well positioned to strengthen the European drug supply chain.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Mongolia Mining 2024 - Digital Interactive

Investors once came to Mongolia for its geology yet stumbled upon its legislative framework. How competitive Mongolia has become today, we will leave our readers to judge, hoping that this report provides them with the resources to make an informed assessment.

PARTNER EVENTS